NCT02390687View on ClinicalTrials.gov

Evaluation of the Efficacy of Probiotics in Chronic Periodontitis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2016

Conditions
Chronic Periodontitis
Interventions
DRUG

Probiotic

Each probiotic lozenge contains not less than 1 billion colony forming unit of Lactobacillus brevis CD2

DRUG

Placebo

Each placebo lozenge contains all excipients except the active constituent (Lactobacillus brevis CD2)

Trial Locations (1)

574327

Department of Periodontics, K.V.G. College & Hospital,, Kurunjibhag, Sullia (d.k.)

All Listed Sponsors
collaborator

KVG Medical College and Hospital

OTHER

lead

Next Gen Pharma India Pvt. Ltd.

INDUSTRY

NCT02390687 - Evaluation of the Efficacy of Probiotics in Chronic Periodontitis Patients | Biotech Hunter | Biotech Hunter